NORTHERN MOSAIC LP
Profile
Company Names
NORTHERN MOSAIC LP
Addresses
101 COLLEGE STREET, PMCRT 15-701, TORONTO, A6 M5G 1L7
Phone Numbers
416-634-7132
Entity Type:
LIMITED PARTNERSHIP
Industry:
BIOTECHNOLOGY
Year Incorporated:
2016
State Incorporated:
MANITOBA, CANADA
Total Amount Raised:
$7,292,116.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2019-06-14
$7,292,116.00
$7,292,116.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRADLEY
BOLZON
DIRECTOR
METABOLEX, INC.
| FLEXION THERAPEUTICS INC
| INCEPTION 3, INC.
| INCEPTION 4, INC.
| VERSANT VENTURE CAPITAL V, L.P.
| VERSANT AFFILIATES FUND V, L.P.
| VERSANT OPHTHALMIC AFFILIATES I, L.P.
| VERSANT VENTURE CAPITAL V (CANADA), LP
| INCEPTION 5, INC.
| INCEPTION IBD, INC.
| CRISPR THERAPEUTICS AG
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| VERSANT VENTURE CAPITAL VI, L.P.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| BLACK DIAMOND THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VII, L.P.
| NORTHERN MOSAIC LP
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| MONTE ROSA THERAPEUTICS, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
JEREL
DAVIS
DIRECTOR
CHANRX CORP.
| LAGUNA PHARMACEUTICALS, INC.
| INCEPTION IBD, INC.
| TRAVUS THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VI, L.P.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| VERSANT VENTURE CAPITAL VII, L.P.
| TURNSTONE BIOLOGICS CORP.
| NORTHERN MOSAIC LP
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| CHINOOK THERAPEUTICS U.S., INC.
| VENTUS THERAPEUTICS U.S., INC.
| TENTARIX BIOTHERAPEUTICS, LP
| RAYZEBIO, INC.
| GRAPHITE BIO, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| SANTA ANA BIO, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| FIREFLY BIO, INC.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
DARLENE
DEPTULA-HICKS
EXECUTIVE OFFICER
(GENERAL PARTNER OF THE ISSUER)
NORTHERN BIOLOGICS GP CORPORATION
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
